Jean-Claude Carel
APHP - hôpital Robert Debré - Paris · APHP · Assistance Publique - Hôpitaux de Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jean-Claude Carel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:02 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07880769 · Verapamil In Preclinical Type 1 DiabetesAssistance Publique - Hôpitaux de Paris · not yet recruiting · Type 1 Diabetes · principal investigator
- N/ANCT02617251 · Impact of Deprivation on Hospital Care Efficiency in PaediatricsAssistance Publique - Hôpitaux de Paris · completed · Deprivation · principal investigator
- N/ANCT01687842 · Social Cognition and Turner SyndromeAssistance Publique - Hôpitaux de Paris · completed · Turner Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:02 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.N Engl J Med · 2012258 citationsRCR 6.7
- 185 citationsRCR 3.5
- Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.J Clin Endocrinol Metab · 1999134 citationsRCR 4.1
- Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study.J Clin Endocrinol Metab · 2003105 citationsRCR 3.2
- Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.Diabetologia · 202089 citationsRCR 3.8
- Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study.J Clin Endocrinol Metab · 199985 citationsRCR 2.9
- Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).J Clin Endocrinol Metab · 200279 citationsRCR 2.3
- Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.Diabetologia · 199864 citationsRCR 1.5
- Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.J Clin Endocrinol Metab · 199856 citationsRCR 2.1
- Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.Eur J Endocrinol · 200648 citationsRCR 1.7